• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:陆珊珊,赵玉荣,葛正萍,邹赟杰,杨晓敏,姚俊宏,陈军.基于网络药理学和分子对接技术分析少腹逐瘀汤治疗盆腔炎的作用机制及功效成分含量测定[J].药学研究,2023,42(8):543-550,561[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3104次   下载 3526次 本文二维码信息
码上扫一扫!
基于网络药理学和分子对接技术分析少腹逐瘀汤治疗盆腔炎的作用机制及功效成分含量测定
陆珊珊1,2,赵玉荣1,葛正萍1,邹赟杰1,杨晓敏1,姚俊宏2,陈军2,3
字体:加大+|默认|缩小-
(1.南京中医药大学翰林学院,江苏 泰州 225300;2.南京中医药大学,江苏省中医外用药开发与应用工程研究中心,江苏 南京 210023;3.南京中医药大学,江苏省中药资源产业化过程协同创新中心,江苏 南京 210023)
摘要:
目的 基于网络药理学和分子对接技术分析少腹逐瘀汤治疗盆腔炎潜在的分子作用机制,并利用HPLC-DAD建立功效物质基础含量的测定方法。方法 根据网络数据平台对少腹逐瘀汤的各味中药成分进行收集和筛选,获得了218种活性成分,得到了199个药物成分的靶点,建立“中药-药物成分-靶点”交互作用网络,筛选出关键功效物质基础。同时查找到2558个盆腔炎相关的治疗靶点,取交集后得97个少腹逐瘀汤和盆腔炎的作用靶点,建立蛋白交互作用网络,筛选出70个核心蛋白,其中包括SRC,MAPK1和HSP90AA1。通过Metascape数据库对交集靶点进行富集分析。采用AutoDock Tools,Pymol等软件对以上过程所得结果进行分析和验证。此外,还对功效成分建立含量测定方法完成对少腹逐瘀汤中功效成分的含量测定。结果 少腹逐瘀汤与盆腔炎的共同生物学过程包括激素的响应、激酶活性的调节等;作用通路主要为癌症通路、脂质代谢与动脉粥样硬化通路、MAPK信号通路、PI3K-Akt信号通路等。分子对接的结果显示功效成分能与核心蛋白稳定的结合,并通过相关的残基进行对接,发生相互作用。结论 该研究为少腹逐瘀汤治疗盆腔炎的作用机制提供了思路,建立的功效成分含量测定方法准确、稳定,为临床应用中质量控制环节提供参考。
关键词:  网络药理学  分子对接  少腹逐瘀汤  盆腔炎  作用机制  含量测定
DOI:10.13506/j.cnki.jpr.2023.08.002
基金项目:国家自然科学基金(No.82173994);江苏省高校自然科学面上项目(No.21KJB360020);2022年江苏省大学生创新创业训练项目(No.202213981005Y、202213981013Y);2022年泰州市“凤城英才”人才项目;2022年泰州市科技支撑计划(社会发展)项目(No.SSF20220031)
出版日期:2023-08-25
The mechanism of Shaofu Zhuyu Decoction in the treatment of pelvic inflammatory disease and the determination of the content of functional components were studied based on network pharmacology and molecular docking technology
LU Shanshan1,2,ZHAO Yurong1,GE Zhengping1,ZOU Yunjie1,YANG Xiaomin1,YAO Junhong2,CHEN Jun2,3
(1.Hanlin College, Nanjing University of Chinese Medicine, Taizhou 225300, China; 2.Nanjing University of Chinese Medicine, Jiangsu Provincial Engineering Research Center of TCM External Medication Development and Application, Nanjing 210023, China;3.Nanjing University of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing 210023, China)
Abstract:
Objective To analyze the potential molecular mechanism of (SZD) (SZD) in the treatment of pelvic inflammatory disease based on network pharmacology and molecular docking technology, and to establish a method for the determination of the content of functional material basis by HPLC-DAD. Methods According to the network data platform, the traditional Chinese medicine components of (SZD) were collected and screened, 218 active components were obtained, and the targets of 199 drug components were obtained. The “traditional Chinese medicine-drug component-target” interaction network was established to screen out the key functional material basis. At the same time, 2558 therapeutic targets related to pelvic inflammatory disease were found, and 97 targets of (SZD) and pelvic inflammatory disease were obtained after intersection. The protein interaction network was established, and 70 core proteins were screened, including SRC, MAPK1 and HSP90AA1. Enrichment analysis of intersection targets was performed by Metascape database. The results obtained from the above process were analyzed and verified by AutoDock Tools, Pymol and other software. In addition, the content determination method of functional components was established to complete the content determination of functional components in (SZD).Results The common biological processes of (SZD) and pelvic inflammatory disease include hormone response, regulation of kinase activity, etc. The main pathways are cancer pathway, lipid metabolism and atherosclerosis pathway, MAPK signaling pathway, PI3K-Akt signaling pathway and so on. The results of molecular docking showed that the functional components could bind to the core protein stably and interact with each other through the related residues. Conclusion This study provides ideas for the mechanism of (SZD) in the treatment of pelvic inflammatory disease. The established method for the determination of the content of functional components is accurate and stable, and provides a reference for quality control in clinical application.
Key words:  Network pharmacology  Molecular docking  Shaofu Zhuyu Decoction  Pelvic inflammatory disease  Mechanism of action  Assay
今日访问量:2331    总访问量:55338700
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司